اثربخشی دارو درمانی بر کارکردهای اجرایی، مشکلات رفتاری و نشانگان بالینی اختلال نارسایی توجه/بیش فعالی

1. Polanczyk GV, Willcutt EG, Salum GA,
Kieling C, Rohde LA. ADHD prevalence estimates
across three decades: an updated systematic review
and meta-regression analysis. International journal of
epidemiology. 2014;43(2):434-42.
2. Skounti M, Philalithis A, Galanakis E.
Variations in prevalence of attention deficit
hyperactivity disorder worldwide. European journal
of pediatrics. 2007;166(2):117-23.
3. Association AP. Diagnostic and statistical
manual of mental disorders (DSM-5®): American
Psychiatric Pub; 2013.
4. Polanczyk GV, Salum GA, Sugaya LS, Caye
A, Rohde LA. Annual Research Review: A
meta‐analysis of the worldwide prevalence of mental
disorders in children and adolescents. Journal of child
psychology and psychiatry. 2015;56(3):345-65.
5. Sayal K, Prasad V, Daley D, Ford T, Coghill
D. ADHD in children and young people: prevalence,
care pathways, and service provision. The Lancet
Psychiatry. 2018;5(2):175-86.
6. Miller M, Hinshaw SP. Does childhood
executive function predict adolescent functional
outcomes in girls with ADHD? Journal of abnormal
child psychology. 2010;38(3):315-26.
7. Sella F, Re AM, Lucangeli D, Cornoldi C,
Lemaire P. Strategy selection in ADHD
characteristics children: A study in arithmetic.
Journal of attention disorders. 2019;23(1):87-98.
8. najarzadegan maryam, Nejati Vahid , Amiri
Nasrin. Effect of Cognitive Rehabilitation of
Working Memory in Reducing Behavioral Symptoms
(Attention Deficit and Impulsivity) of Children with
Attention Deficit and Hyperactivity Disorder Journal
of Neuropsychology. 2015;1(1):52-45.
9. Gray C, Climie EA. Children with attention
deficit/hyperactivity disorder and reading disability:
A review of the efficacy of medication treatments.
Frontiers in psychology. 2016;7:988.
10. Scheres A, Oosterlaan J, Geurts H, MoreinZamir S, Meiran N, Schut H, et al. Executive
functioning in boys with ADHD: primarily an
inhibition deficit? Archives of clinical
neuropsychology. 2004;19(4):569-94.
11. Serpell ZN, Esposito AG. Development of
executive functions: Implications for educational
policy and practice. Policy Insights from the
Behavioral and Brain Sciences. 2016;3(2):203-10.
12. Yasumura A, Omori M, Fukuda A, Takahashi
J, Yasumura Y, Nakagawa E, et al. Age-related
differences in frontal lobe function in children with
ADHD. Brain and Development. 2019;41(7):577-86.
13. Soriano-Ferrer M, Félix-Mateo V, Begeny J.
Executive function domains among children with
ADHD: Do they differ between parents and teachers
ratings? Procedia-Social and Behavioral Sciences.
2014;132:80-6.
14. Magnus W, Nazir S, Anilkumar AC, Shaban
K. Attention Deficit Hyperactivity Disorder (ADHD).
2017.
15. Bakhshayesh AR, Hänsch S, Wyschkon A,
Rezai MJ, Esser G. Neurofeedback in ADHD: a
single-blind randomized controlled trial. European
child & adolescent psychiatry. 2011;20(9):481-91.
16. Kirov R, Brand S. Sleep problems and their
effect in ADHD. Expert review of neurotherapeutics.
2014;14(3):287-99.
17. Campbell B, Kreider RB, Ziegenfuss T, La
Bounty P, Roberts M, Burke D, et al. International
Society of Sports Nutrition position stand: protein
and exercise. Journal of the international society of
sports nutrition. 2007;4(1):1-7.
18. Caye A, Swanson JM, Coghill D, Rohde LA.
Treatment strategies for ADHD: an evidence-based
guide to select optimal treatment. Molecular
psychiatry. 2019;24(3):390-408.
19. Wigal SB, Maltas S, Crinella F, Stehli A,
Steinhoff K, Lakes K, et al. Reading performance as
a function of treatment with lisdexamfetamine
dimesylate in elementary school children diagnosed
with ADHD. Journal of attention disorders.
2012;16(1):23-33.
20. Galland BC, Tripp EG, Taylor BJ. The sleep
of children with attention deficit hyperactivity
disorder on and off methylphenidate: a matched
case–control study. Journal of sleep research.
2010;19(2):366-73.
21. Sattari M, Hosseini SA, Rassafiani M,
Mahmoudi Gharaei MJ, Biglarian A, Tarkesh
Esfahani N. Prevalence of Comorbidity Behavioral
Disorders in Children With Attention Deficit
Hyperactivity. Archives of Rehabilitation.
2017;18(1):25-32.
22. Mohammad Esmaeel E. Adaptation and
Standardization of Child Symptom Inventory-4 (CSI4). Journal of Exceptional Children. 2007;7(1):79-96.
23. Shima Sahim. Investigation of short-scale and
boring forms of children for use in Iran Journal of
Social Sciences and Humanities, Shiraz University
1994;18:67-79.
24. Bussing R, Fernandez M, Harwood M, Hou
W, Garvan CW, Eyberg SM, et al. Parent and teacher
SNAP-IV ratings of attention deficit hyperactivity
disorder symptoms: psychometric properties and
normative ratings from a school district sample.
Assessment. 2008;15(3):317-28.
25. Coolidge FL, Thede LL, Jang KL. Are
personality disorders psychological manifestations of
executive function deficits? Bivariate heritability
evidence from a twin study. Behavior Genetics.
2004;34(1):75-84.
26. Alizadeh Hamid. Theoretical explanation of
Attention Deficit / Hyperactivity Disorder: Behavioral Inhibition Pattern and the nature of selfcontrol exceptional Children 2005;17(5):323-48.
27. Yosefi Farideh. Standardization of Rutter
Questionnaire to Assess the Behavioral and
Emotional Problems of Male and Female Students in
Shiraz Primary Schools. Social Sciences and
Humanities, Shiraz University 1988;13(1-2):171-94.
28. Taş Torun Y, Işik Taner Y, Güney E, İseri E.
Osmotic Release Oral System-Methylphenidate
Hydrochloride (OROS-MPH) versus atomoxetine on
executive function improvement and clinical
effectiveness in ADHD: A randomized controlled
trial. Applied Neuropsychology: Child. 2020:1-12.
29. Yildiz O, Sismanlar SG, Memik NC,
Karakaya I, Agaoglu B. Atomoxetine and
methylphenidate treatment in children with ADHD:
the efficacy, tolerability and effects on executive
functions. Child Psychiatry & Human Development.
2011;42(3):257-69.
30. Gau SS-F, Shang C-Y. Improvement of
executive functions in boys with attention deficit
hyperactivity disorder: an open-label follow-up study
with once-daily atomoxetine. International Journal of
Neuropsychopharmacology. 2010;13(2):243-56.
31. Brown TE, Holdnack J, Saylor K, Adler L,
Spencer T, Williams DW, et al. Effect of atomoxetine
on executive function impairments in adults with
ADHD. Journal of attention disorders.
2011;15(2):130-8.
32. Overtoom C, Verbaten M, Kemner C,
Kenemans J, Van Engeland H, Buitelaar J, et al.
Effects of methylphenidate, desipramine, and L-dopa
on attention and inhibition in children with attention
deficit hyperactivity disorder. Behavioural brain
research. 2003;145(1-2):7-15.
33. Khoushabi K, Shamsaee MM, Jadidi M,
Nikkhah H, Basteh Hoseini S, Malek Khosravi G. A
Comparative Study on the Effectiveness of Stimulant
Therapy (Ritalin) Neurofeedback, and Parental
Management Training and Interaction of the Three
Approaches on Improving ADHD and Quality of
Mother -Child Communication. Avicenna Journal of
Clinical Medicine. 2013;20(2):133-43.
34. Dodangi Nasrin, Habibi Nastaran.
Comparison of duloxetine and methylphenidate in the
treatment of children with attentiondeficit/hyperactivity disorder Tehran University
Medical Journal. 2016;74(3).
35. Owens J. Relationships between an ADHD
Diagnosis and Future School Behaviors among
Children with Mild Behavioral Problems. Sociology
of Education. 2020;93(3):191-214.
36. Häge A, Hohmann S, Millenet S,
Banaschewski T.
Aufmerksamkeitsdefizit‑/Hyperaktivitätsstörung im
Kindes-und Jugendalter. Der Nervenarzt.
2020;91(7):599-603.
37. Bai G-n, Wang Y-f, Yang L, Niu W-y.
Effectiveness of a focused, brief psychoeducation
program for parents of ADHD children: improvement
of medication adherence and symptoms.
Neuropsychiatric Disease and Treatment.
2015;11:2721.